Valuation: Azenta, Inc.

Market Cap 1.64B 8.45B 1.4B 1.31B 1.2B 2.27B 157B 2.29B 15.55B 6.05B 78.73B 6.15B 6.02B 261B P/E 2026 *
-9.1x
P/E 2027 * 1,879x
Enterprise Value 1.64B 8.45B 1.4B 1.31B 1.2B 2.27B 157B 2.29B 15.55B 6.05B 78.73B 6.15B 6.02B 261B EV / Sales 2026 *
2.66x
EV / Sales 2027 * 2.55x
Free-Float
75.69%
Yield 2026 *
-
Yield 2027 * -
1 day-0.62%
1 week-0.62%
Current month+18.53%
1 month+21.54%
3 months+42.33%
6 months+17.57%
Current year-7.87%
1 month 12.11
Extreme 12.11
14.48
Current year 8.9
Extreme 8.9
17.7
1 year 8.9
Extreme 8.9
17.7
3 years 8.9
Extreme 8.9
29.07
5 years 8.9
Extreme 8.9
40.04
10 years 8.9
Extreme 8.9
40.04
Manager TitleAgeSince
Chief Executive Officer 45 2024-09-08
Director of Finance/CFO 49 2024-11-30
Chief Tech/Sci/R&D Officer - 2017-06-30
Director TitleAgeSince
Director/Board Member 64 2013-06-27
Director/Board Member 50 2020-04-02
Chairman 72 2024-01-29
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%-0.62% - - 1.64B
-0.74%+4.48%+3.74%+22.46% 51.61B
+1.01%+3.86%+471.68%+577.49% 44.89B
+0.16%+9.96%+36.14%+20.40% 42.77B
-0.66%+7.05%+18.59%+83.42% 42.58B
+0.88%-3.48%+17.20%+57.20% 31.82B
-0.12%+7.18%+33.73%+148.24% 17.33B
-0.53%+1.39% - - 16.63B
+0.58%+4.00%+7.17%+30.59% 14.76B
+1.15%+6.62%+84.49%+47.81% 14.09B
Average +0.11%+4.83%+84.09%+123.45% 30.72B
Weighted average by Cap. +0.10%+5.13%+100.58%+142.48%

Financials

2026 *2027 *
Net sales 615M 3.17B 527M 494M 451M 851M 58.88B 860M 5.84B 2.27B 29.56B 2.31B 2.26B 97.89B 641M 3.31B 550M 515M 470M 888M 61.39B 897M 6.09B 2.37B 30.82B 2.41B 2.36B 102B
Net income -164M -848M -141M -132M -121M -228M -15.74B -230M -1.56B -607M -7.9B -617M -604M -26.17B 16.2M 83.55M 13.89M 13M 11.88M 22.43M 1.55B 22.66M 154M 59.78M 778M 60.82M 59.49M 2.58B
Net Debt - -
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
2,900
Date Price Change Volume
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
32.88USD
Average target price
35.25USD
Spread / Average Target
+7.21%

Quarterly revenue - Rate of surprise